Valion Bio (VBIO) Change in Accrued Expenses (2021 - 2026)
Valion Bio's Change in Accured Expenses was $209,000 in Q4 2025, compared with -$80,000 a year earlier.
Powered by 
Analysis
Valion Bio (VBIO) Change in Accrued Expenses (2021 - 2026) Analysis & Trends
For FY2025, Change in Accured Expenses at Valion Bio came in at $235,000.
- Change in Accured Expenses shows a four-year compound annual growth rate of 16.4% (FY2021 to FY2025).
- In earlier years, Change in Accured Expenses was -$348,000 in FY2024, $103,000 in FY2023 (-5.5%), $109,000 in FY2022 (-14.8%) and $128,000 in FY2021.
- The Q4 2025 figure marks the highest quarterly Change in Accured Expenses since Q4 2023.
- Per Business Quant data, VBIO's Change in Accured Expenses in the three quarters before Q4 2025 was -$327,000 (Q3 2025), $197,000 (Q2 2025) and $156,000 (Q1 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change Accrued Exp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,359.75 Bn | 1,333.37 Bn | 20.46 Bn | - |
| 2 | Johnson & Johnson | 688.76 Bn | 608.62 Bn | 17.30 Bn | 2.41 Bn |
| 3 | AbbVie | 521.69 Bn | 489.75 Bn | 13.12 Bn | 983.00 Mn |
| 4 | Merck | 364.31 Bn | 327.31 Bn | 13.19 Bn | - |
| 5 | Novartis Ag | 306.35 Bn | 279.93 Bn | - | - |
| 6 | Astrazeneca | 285.96 Bn | 259.56 Bn | 13.26 Bn | - |
| 7 | Amgen | 251.88 Bn | 203.53 Bn | 7.58 Bn | -87.00 Mn |
| 8 | Gilead Sciences | 208.59 Bn | 183.61 Bn | 6.73 Bn | 756.00 Mn |
| 9 | Pfizer | 164.73 Bn | 112.38 Bn | 12.56 Bn | - |
| 10 | Valion Bio | 73,008.00 | -25.39 Mn | - | 341,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 341,000.00 |
| Mar 31, 2026 | 1.11 Mn |
| Dec 31, 2025 | 209,000.00 |
| Sep 30, 2025 | -327,000.00 |
| Jun 30, 2025 | 197,000.00 |
| Mar 31, 2025 | 156,000.00 |
| Dec 31, 2024 | -80,000.00 |
| Sep 30, 2024 | 82,000.00 |
| Jun 30, 2024 | -120,000.00 |
| Mar 31, 2024 | -230,000.00 |
| Dec 31, 2023 | 287,000.00 |
| Sep 30, 2023 | 45,000.00 |
| Jun 30, 2023 | -153,000.00 |
| Mar 31, 2023 | -76,000.00 |
| Dec 31, 2022 | 115,000.00 |
| Sep 30, 2022 | -32,000.00 |
| Jun 30, 2022 | -10,000.00 |
| Mar 31, 2022 | 36,000.00 |
| Dec 31, 2021 | -39,000.00 |
| Sep 30, 2021 | 7,000.00 |
API Access
Valion Bio Change in Accrued Expenses API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=change-in-accured-expenses&ticker=VBIO&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "change-in-accured-expenses", "ticker": "VBIO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=change-in-accured-expenses&ticker=VBIO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();